Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 13, 2024
Discovery & Translation

Science Spotlight: How extrachromosomal DNA drives cancer

BioCentury’s roundup of translational innovation features two trios of papers: one on genetic control of cancer and the other on MASLD markers
BioCentury | May 17, 2019
Tools & Techniques

Leaning on exosomes, model-informed drug development gets closer to tailoring doses to each patient

How liquid biopsies could lead to the next big step in modeling dose levels for precision medicine.
BioCentury | Aug 4, 2011
Tools & Techniques

Metabolically, man or mouse

BioCentury | Mar 25, 2011
Financial News

AssureRx raises $11 million in series B

BioCentury | Feb 21, 2011
Company News

AssureRx sales and marketing update

BioCentury | Mar 15, 2010
Company News

AssureRx sales and marketing update

BioCentury | Apr 16, 2007
Clinical News

Zanaflex tizanidine regulatory update

BioCentury | May 7, 2001
Company News

Maxygen other research news

Items per page:
1 - 9 of 9